Rosalinda Roselli Selected Research

Rosalinda Roselli Research Topics

Disease

9	Inflammation (Inflammations) 12/2023 - 08/2019
6	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2022
5	Fatty Liver 12/2023 - 01/2022
4	Colitis 02/2023 - 01/2020
3	Insulin Resistance 12/2023 - 11/2022
2	Dysbiosis 12/2023 - 06/2020
2	Fibrosis (Cirrhosis) 01/2023 - 11/2022
2	Chemical and Drug Induced Liver Injury 01/2023 - 01/2020
2	Neoplasms (Cancer) 01/2022 - 01/2021
1	Hypotension (Low Blood Pressure) 12/2023
1	Atherosclerosis 12/2023
1	Body Weight (Weight, Body) 12/2023
1	Autoimmune Diseases (Autoimmune Disease) 02/2023
1	Adenocarcinoma 11/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Peritoneal Diseases 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Vascular System Injuries 01/2022
1	Carcinogenesis 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2020
1	Disease Progression 01/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Cholestasis 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020
1	Hepatitis 01/2019

Drug/Important Bio-Agent (IBA)

8	Bile Acids and Salts (Bile Acids)IBA 12/2023 - 01/2022
4	LigandsIBA 12/2023 - 01/2022
4	GTP-Binding Proteins (G-Protein)IBA 12/2023 - 01/2022
4	Interleukin-6 (Interleukin 6)IBA 11/2022 - 08/2019
3	LipidsIBA 01/2023 - 01/2022
3	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2023 - 01/2020
3	CytokinesIBA 01/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2022 - 06/2020
2	Atorvastatin (Lipitor)FDA Link 12/2023 - 01/2022
2	BAR502IBA 12/2023 - 01/2023
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 01/2022
2	CholesterolIBA 12/2023 - 01/2022
2	ApolipoproteinsIBA 12/2023 - 12/2023
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 01/2022
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2023 - 01/2023
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2023 - 11/2022
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 08/2019
2	pelargonidinIBA 01/2021 - 08/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2023
1	6-ethyl-3,7-dihydroxycholan-24-olIBA 12/2023
1	Apolipoproteins E (ApoE)IBA 12/2023
1	FructoseIBA 12/2023
1	Sulfonic AcidsIBA 02/2023
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2023
1	sym-trinitrobenzeneIBA 02/2023
1	LeukotrienesIBA 01/2023
1	ChemokinesIBA 01/2023
1	Mifepristone (RU 486)FDA Link 11/2022
1	AdiponectinIBA 11/2022
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	OSM-LIF ReceptorsIBA 01/2022
1	EstersIBA 01/2021
1	FlavonoidsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	GlycosidesIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 06/2020
1	Bacterial AntigensIBA 06/2020
1	zafirlukast (Accolate)FDA LinkGeneric 01/2020
1	pranlukastIBA 01/2020
1	isothiocyanic acidIBA 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	obeticholic acidIBA 01/2020
1	montelukast (Singulair)FDA Link 01/2020
1	4-aminophenolIBA 01/2020
1	Galactosylceramides (Galactocerebrosides)IBA 01/2019
1	Concanavalin AIBA 01/2019

Therapy/Procedure

4	Therapeutics 02/2023 - 01/2021
1	Ligation 01/2020
1	Liver Transplantation 01/2020